Viewing Study NCT04049461


Ignite Creation Date: 2025-12-24 @ 11:51 AM
Ignite Modification Date: 2025-12-31 @ 1:50 AM
Study NCT ID: NCT04049461
Status: NOT_YET_RECRUITING
Last Update Posted: 2019-08-08
First Post: 2019-08-06
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Heterotopic Ossification in Abdominal Incision and Pancreatic Cancer
Sponsor: Nanjing Medical University
Organization:

Study Overview

Official Title: The Causes of Heterotopic Ossification in Abdominal Incision After Pancreatic Surgery:A Single-center Prospective Study
Status: NOT_YET_RECRUITING
Status Verified Date: 2019-08
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: To investigate whether pancreatic cancer is the cause of heterotopic ossification of abdominal incision.
Detailed Description: Heterotopic ossification of abdominal incision (HOAI) has long been regarded as a rare complication after general surgery. However,according to our retrospective analysis. HOAI was more frequently observed in the malignancy group (33/121 cases, 27.3%) than in the non- malignancy group. Because of the many biases in the retrospective analysis, the result was not widely shared.

The purpose of this prospective study is to confirm that pancreatic cancer is the cause of heterotopic ossification of abdominal incisions. According to postoperative pathology, the patients were divided into two groups: pancreatic cancer group and benign diseases group.The researchers will observe whether patients develop heterotopic ossification of the abdominal incision one year after surgery to conclude.

Study Oversight

Has Oversight DMC: False
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: